AI Overview

La DP cherche un ou des fournisseur(s) de seringues intravitréennes préremplies à usage unique contenant des médicaments anti-VEGF pour les traitements ophtalmiques dans le cadre du Programme provincial de traitement des maladies rétiniennes.

Information de base

Numéro de Référence

00004875376

Organisation émettrice

Provincial Health Services Authority BC

Type d’appel d’offres

DDP - Demande de proposition (Formel)

Numéro d’appel d’offres

224141

Titre

RFP PHSA 16956 Provincial Retinal Diseases Treatment Program (PRDTP) Pharmacy Services

Code d’identité d’origine

SCRIBE

Détails

Emplacement

Colombie Britannique

Type d’achat

Non-mentionné

Dates

Publication

2026-01-26 08h03:00 HNE

Date de fermeture

2026-03-06 17h00:00 HNE

Information du contact

Provincial Health Services Authority

604-675-7400

Description

This RFP is being issued by Provincial Health Services Authority (“PHSA”) to identify a Proponent or Proponent(s) to enter into a non-exclusive Contract between the Proponent(s) and the PHSA, for the supply of single-use intravitreal prefilled syringes containing anti-vascular endothelial growth factor (anti-VEGF) drugs for use in ophthalmic treatments, to the Provincial Retinal Diseases Treatment Program (“PRDTP”) (a program of PHSA) at their program clinics.

Afficher davantage

Dérogation All amendments to the associated notice, including amended documents, plans and specifications (where applicable), are issued on bcbid.gov.bc.ca. MERX asks that you refer to bcbid.gov.bc.ca notice for these amendments. MERX stipulates that potential bidders may also be required to register with the buying authority as a bidder/plan taker. The contact information can be found within the notice abstract.